Health

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon Hadlima (adalimumab-bwwd) Injection

DailyTrendDailyTrend
May 27, 2025 - 23:00
 0  0
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon Hadlima (adalimumab-bwwd) Injection
INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE) May 27, 2025 -- Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the Hadlima™ (adalimumab-bwwd)...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

A New Way to Reduce Children’s Deaths: Cash

A New Way to Reduce Children’s Deaths: Cash

DailyTrend Aug 18, 2025  0  0

A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply

A $45 Treatment Can Save a Starving Child. US Aid Cuts ...

DailyTrend Aug 16, 2025  0  0

Are Marathons and Extreme Running Linked to Colon Cancer?

Are Marathons and Extreme Running Linked to Colon Cancer?

DailyTrend Aug 20, 2025  0  0

Sport Psychology Tips for Everyday Life

Sport Psychology Tips for Everyday Life

DailyTrend Aug 21, 2025  0  0

B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter

B. Braun Medical Issues Voluntary Nationwide Recall of ...

DailyTrend Aug 20, 2025  0  0

Trump’s Get-Tough Approach on Homelessness May Sweep Up Veterans

Trump’s Get-Tough Approach on Homelessness May Sweep Up...

DailyTrend Aug 19, 2025  0  0